CD4 + T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD4 + T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro

Published:2000-01-12 Issue:11 Volume:48 Page:621-626
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:
Short-container-title:Cancer Immunology, Immunotherapy

Author:

Brady Mary S.,Lee Fei,Petrie H.,Eckels David D.,Lee Janet S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s002620050010.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma;International Immunopharmacology;2021-07

2. Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery;AAPS PharmSciTech;2020-06-08

3. Cancer immunology and canine malignant melanoma: A comparative review;Veterinary Immunology and Immunopathology;2016-01

4. Targeted Tumor Immunotherapy: Are Vaccines the Future of Cancer Treatment?;Current Drug Therapy;2015-04-01

5. CD8+ T Cell–Independent Tumor Regression Induced by Fc-OX40L and Therapeutic Vaccination in a Mouse Model of Glioma;The Journal of Immunology;2013-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP